NanoFerix has signed an agreement with Vanderbilt's Center for Technology Transfer and Commercialization to research technology to market to pharmaceutical companies.

US-based Vanderbilt University’s technology transfer program has signed its first local start-up in more than two years by backing serial entrepreneur Shawn Glinter’s NanoFerix.

NanoFerix has signed an agreement with Vanderbilt’s Center for Technology Transfer and Commercialization to research technology to market to pharmaceutical companies.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?